Exposure to bisphenol A is associated with low-grade albuminuria in Chinese adults

Kidney International

Volumn 81, Issue 11, 2012, Pages 1131-1139

  Li, Mian ^a,b   Bi, Yufang ^a,b   Qi, Lu ^a   Wang, Tiange ^a   Xu, Min ^b   Huang, Yun ^a   Xu, Yu ^a   Chen, Yuhong ^a   Lu, Jieli ^a   Wang, Weiqing ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

albuminuria; cardiovascular disease; diabetic nephropathy

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALBUMIN; CREATININE;

ADULT; AGE DISTRIBUTION; ALBUMINURIA; ALCOHOL CONSUMPTION; ARTICLE; BIOSAFETY; BODY MASS; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; LONG TERM EXPOSURE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; URINE LEVEL;

EID: 84862798004     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.6     Document Type: Article

References (51)

1. American Diabetes Association. Clinical recommendations 2001: diabetic nephropathy. Diabetes Care 2001; 24: S69-S72.
2. Kidney Disease Outcome Quality Initiative. Amonymous K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
3. Bramlage P, Pittrow D, Lehnert H et al. Frequency of albuminuria in primary care: a cross-sectional study. Eur J Cardiovasc Prev Rehabil 2007; 14: 107-113.
4. Parving HH, Lewis JB, Ravid M et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69: 2057-2063. (Pubitemid 43924271)
5. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17: 2100-2105. (Pubitemid 44141898)
6. Knight EL, Curhan GC. Albuminuria: moving beyond traditional microalbuminuria cut-points. Curr Opin Nephrol Hypertens 2003; 12: 283-284. (Pubitemid 36578063)
7. lausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 11032-35. (Pubitemid 38880131)
8. Talsness CE, Andrade AJM, Kuriyama SN et al. Components of plastic: experimental studies in animals and relevance for human health. Philos Trans R Soc Lond B Biol Sci 2009; 364: 2079-2096.
9. Stahlhut RW, Welshons WV, Swan SH. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect 2009; 117784-789.
10. Quesada I, Fuentes E, Viso-Leon MC et al. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. FASEB J 2002; 16: 1671-1673.
11. Alonso-Magdalena P, Laribi O, Ropero AB et al. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 2005; 113: 969-977. (Pubitemid 41149624)
12. Fang H, Tong W, Perkins R et al. Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect 2000; 108: 723-729.
13. Calafat AM, Kuklenyik Z, Reidy JA et al. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113: 391-395. (Pubitemid 40601814)
14. Bindhumol V, Chitra KC, Mathur PP. Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 2003; 188: 117-124. (Pubitemid 36588894)
15. Elsby R, Maggs JL, Ashby J et al. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J Pharmacol Exp Ther 2001; 297: 103-113. (Pubitemid 32242568)
16. Nakagawa Y, Tayama S. Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch Toxicol 2000; 74: 99-105. (Pubitemid 30304017)
17. Roy D, Palangat M, Chen CW et al. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J Toxicol Environ Health 1997; 50: 1-29.
18. Tyl RW, Myers CB, Marr MC et al. Threegeneration reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 2002; 68: 121-146. (Pubitemid 34785236)
19. Ropero AB, Alonso-Magdalena P, Garcia-Garcia E et al. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 2008; 31: 194-199. (Pubitemid 351341359)
20. Lang IA, Galloway TS, Scarlett A et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300: 1303-1310.
21. Melzer D, Rice NE, Lewis C et al. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 2010; 5: e8673.
22. Vogel SA. The politics of plastics: the making and unmaking of bisphenol a 'safety'. Am J Public Health 2009; 99: 559-566.
23. Laura NV, Maricel VM, Carlos S et al. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009; 30: 75-95.
24. Damsgaard EM, Froland A, Jorgensen OD et al. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300: 297-300. (Pubitemid 20047068)
25. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
26. Jensen JS, Feldt-Rasmussen B, Strandgaard S et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903. (Pubitemid 30303947)
27. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 1988; 2: 530-533.
28. Romundstad S, Holmen J, Hallan H et al. Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trøndelag Health Study (HUNT), Norway. Circulation 2003; 108: 2783-2789.
29. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975. (Pubitemid 41170264)
30. Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc 2008; 83: 806-812. (Pubitemid 351948694)
31. Ingelsson E, Sundstrom J, Lind L et al. Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J 2007; 28: 1739-1745. (Pubitemid 47227087)
32. Lieb W, Mayer B, Stritzke J et al. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant 2006; 21: 2780-2787. (Pubitemid 44542231)
33. Schmieder RE, Schrader J, Zidek W et al. Low-grade albuminuria and cardiovascular risk. Clin Res Cardio 2007; 96: 247-257.
34. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426. (Pubitemid 32681484)
35. Wang TJ, Evans JC, Meigs JB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370-1376. (Pubitemid 40396802)
36. Fang H, Tong W, Perkins R et al. Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect 2000; 108: 723-729.
37. Noguchi S, Nakatsuka M, Asagiri K et al. Bisphenol A stimulates nitric oxide synthesis through a non-genomic estrogen receptor-mediated mechanism in human and mouse endothelial cells. Toxicol Lett 2006; 135: 95-101. (Pubitemid 35266721)
38. Li L, Haynes MP, Bender JR. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci 2003; 100: 4807-4812. (Pubitemid 36457810)
39. Chen DB, Bird IM, Zheng J et al. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004; 145: 113-125. (Pubitemid 38094507)
40. Bouskine A, Nebout M, Mograbi B et al. Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A. Endocrinology 2008; 149: 565-573. (Pubitemid 351159318)
41. Clausen P, Feldt-Rasmussen B, Jensen G et al. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci 1999; 97: 37-43. (Pubitemid 29353893)
42. Clausen P, Jensen JS, Jensen G et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869-1874. (Pubitemid 32328400)
43. Stehouwer CD, Nauta JJ, Zeldenrust GC et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulindependent diabetes mellitus. Lancet 1992; 340: 319-323.
44. Zenere BM, Arcaro G, Saggiani F et al. Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 1995; 18: 975-982.
45. Alonso-Magdalena P, Morimoto S, Ripoll C et al. The estrogenic effect of bisphenol A disrupts pancreatic b-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006; 114: 106-112. (Pubitemid 43056876)
46. Mykkanen L, Zaccaro DJ, Wagenknecht LE et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998; 47: 793-800. (Pubitemid 28201810)
47. Bakker AJ. Detection of microalbuminuria: receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999; 22: 307-313. (Pubitemid 29056927)
48. Eknoyan G, Hostetter T, Bakris GL et al. Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 2003; 42: 617-622. (Pubitemid 37187362)
49. Ning G, Bi Y, Wang T et al. Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults. A cross-sectional analysis. Ann Intern Med 2011; 155: 368-374.
50. Ma YC, Zuo L, Chen JH et al. Modied glomerular ltration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944. (Pubitemid 44484685)
51. He Y, Miao M, Herrinton LJ et al. Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels. Environ Res 2009; 109: 629-633.